Switch of breast tumors to HER2-low in recurrence may provide greater therapeutic options ...Middle East

The finding that breast tumours can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low tumours.

Hence then, the article about switch of breast tumors to her2 low in recurrence may provide greater therapeutic options was published today ( Saturday 08/05/2021 - 02:15 PM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Switch of breast tumors to HER2-low in recurrence may provide greater therapeutic options )

Also on site :

• This Landmark Was Just Ranked ‘Most Loved in the World’—and It's Not the Eiffel Tower
• This Savory New $5 Sam’s Club Snack Puts the Dip in the Chip
• Mindy Kaling Says Her Recent Weight Loss Has Nothing to Do With the Red Carpet